Regio Zuid-Holland | ONCO ID

BIMINI Biotech is developing innovative therapeutics for cancer by specifically blocking the cancer cell growth. We have shown promising results for colorectal cancer, however there is also great potential in treating lung cancer with our technology. This disease is characterized by poor survival rates and a limited availability of effective therapies. As such, there is a strong unmet need for novel approaches...BIMINI envisions to tackle this problem by expanding its currently portfolio to lung cancer. However, before embarking on such a high-risk project, we first need to identify whether this is feasible, both economical and technical, and what the optimal strategy towards the patient is. In this project "ONCO-ID", we will investigate this feasibility. If successfull, we are able to make a huge impact on patient lives, and take one additional step in beating cancer.